Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indofarma Tbk. (INAF) vs Sinarmas Multiartha Tbk. (SMMA) Price & Performance

Indofarma Tbk.Trade
Sinarmas Multiartha Tbk.Trade

Price performance (Past 24H)

Key statistics

Indofarma Tbk. vs Sinarmas Multiartha Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Sinarmas Multiartha Tbk. trades at Rp20,025 (market cap 127.51T, 300 24h volume). The key difference: Sinarmas Multiartha Tbk. is far larger — about 326.5× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.

INAFSMMA
Market Cap
390.51B127.51T
Volume
300
Lot
3
Turnover
6M
Average Price
20,008.33
Value
6M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INAF
View details
SMMA
View details

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF

About Sinarmas Multiartha Tbk.

PT Sinar Mas Multiartha Tbk was established by Deed No. 60 dated October 21, 1982 from Benny Kristianto, S.H., notary in Jakarta. PT Sinar Mas Multiartha was initially active in commercial leasing, consumer financing and venture capital, and purely became a holding company in the Sinar Mas Group.

Read more on SMMA